Researchers at King’s College London have used single cell RNA sequencing to identify a type of cell that may be able to regenerate liver tissue, treating liver failure without the need for transplants.
In a paper published today in Nature Communications, the scientists have identified a new type of cell called a hepatobiliary hybrid progenitor (HHyP), that forms during our early development in the womb. Surprisingly, HHyP also persists in small quantities in adults and these cells can grow into the two main cell types of the adult liver (Hepatocytes and Cholangiocytes) giving HHyPs stem cell-like properties.
The team examined HHyPs and found that they resemble mouse stem cells which have been found to rapidly repair mice liver following major injury, such as occurs in cirrhosis.
For the first time, we have found that cells with true stem cell-like properties may well exist in the human liver. This, in turn, could provide a wide range of regenerative medicine applications for treating liver disease, including the possibility of bypassing the need for liver transplants.– Lead author Dr Tamir Rashid from the Centre for Stem Cells & Regenerative Medicine
Liver disease is the fifth biggest killer in the UK* and the third most common cause of premature death, and the number of cases is continuing to rise. It can be caused by lifestyle issues such as obesity, viruses, alcohol misuse or by non-lifestyle issues such as autoimmune and genetic mediated disease.
Symptoms of liver disease include jaundice, itching and feelings of weakness and tiredness and in more severe cases, cirrhosis. The only treatment for severe liver diseases at present is a liver transplant which can lead to a lifetime of complications and for which the need for donor organs greatly outweighs the increasing demands.
We now need to work quickly to unlock the recipe for converting pluripotent stem cells into HHyPs so that we could transplant those cells into patients at will. In the longer term, we will also be working to see if we can reprogramme HHyPs within the body using traditional pharmacological drugs to repair diseased livers without either cell or organ transplantation/– Dr Rashid
Read the paper here.
Learn more: Liver transplants could be redundant with discovery of new liver cell
The Latest on: Tissue regeneration
[google_news title=”” keyword=”tissue regeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Tissue regeneration
- Heart, Wound, and Inflammation Research and TB-500 Peptideon April 27, 2024 at 1:12 am
Researchers interested in exploring the possible properties of the TB-500 peptide will ...
- Japanese researchers test cardiac spheroids for heart regeneration in monkeyson April 26, 2024 at 9:33 pm
Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function.
- Tissue Engineering and Regeneration Market [2028]: Navigating Opportunities and Challengeson April 24, 2024 at 3:11 am
USD 14.57 billion in 2022 and is poised for substantial growth, projecting a Compound Annual Growth Rate (CAGR) of 8.35% through 2028.
- Technion breakthrough for better drug delivery and tissue implantationon April 23, 2024 at 2:11 pm
Researchers develop ultrasound for non-invasive method for bio-printing live cells and tissues deep within the body.
- New small molecule helps scientists study regenerationon April 23, 2024 at 9:23 am
Regenerating damaged tissues or organs has been a dream of scientists for decades. Now, researchers at the FMI and Novartis Biomedical Research have discovered a new molecule that activates a protein ...
- Secrets of zebrafish heart regeneration could transform human cardiac careon April 20, 2024 at 12:30 pm
Zebrafish heart tissue regeneration is a captivating prospect for transformative advances in human cardiac care ...
- Why zebrafish can regenerate damaged heart tissue, while other fish species cannoton April 19, 2024 at 8:16 am
A heart attack will leave a permanent scar on a human heart, yet other animals, including some fish and amphibians, can clear cardiac scar tissue and regrow damaged muscle as adults.
- $33 Million to Truly Regenerate Arthritic Jointson April 19, 2024 at 8:12 am
Duke School of Medicine, Boston Children’s Hospital, and University of California Los Angeles (UCLA) have been awarded a contract of up to $33 million from the Advanced Research Projects Agency for ...
- Cherokee Nation hosts ARPA-H’s novel osteoarthritis regeneration programon April 18, 2024 at 10:30 am
The Cherokee Nation recently hosted a successful kick-off event for the Advanced Research Projects Agency for Health's Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program. The ...
- Organ regeneration startup names veteran CEO as new leaderon April 18, 2024 at 3:30 am
The new chief executive of Morphoceuticals will chart the company's path into a relatively new and unknown field: Organ regeneration and tissue repair.
via Bing News